Multiple myeloma is a chronic blood cancer affecting plasma cells, but with today’s treatments many patients can manage symptoms and live fulfilling lives.

AUSTIN, TX, UNITED STATES, August 22, 2025 /EINPresswire.com/ -- Overview of the Market: The Global Biopharmaceuticals Market ...

As the U.S. stock market experiences a downturn with the S&P 500 declining for a fourth consecutive day, investors are keenly focused on upcoming signals from Federal Reserve Chair Jerome Powell ...

LONDON, GREATER LONDON, UNITED KINGDOM, August 21, 2025 /EINPresswire.com/ -- What Is The Leukemia Inhibitory Factor (LIF) Market Size And Growth? The market size for Leukemia Inhibitory Factor (LIF) ...

The UK market has recently experienced a downturn, with the FTSE 100 and FTSE 250 indices closing lower amid weak trade data from China, highlighting ongoing global economic challenges. In such ...

According to MarketsandMarkets, the global enzymes market is experiencing robust growth, driven by innovations in biotechnology, increasing demand in biopharmaceutical production, and rising ...

The chromatography resin market is expanding steadily, driven by rising demand in pharmaceuticals, biotechnology, and food & beverage sectors. With c ...

Developers Invivyd, Inc. are working on a plan with the FDA that will see their antibody-based product approved if it passes ...

A major investment project at the BelVitunipharm enterprise is to be implemented by 2030, Vitebsk Oblast Governor Aleksandr ...

WALTHAM, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the quarter ended June 30, 2025, and provided recent business highlights.

Scientists at the University of Virginia School of Medicine and the University of Michigan have developed a monoclonal ...